Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

HYPERTENSION MEETING 2022

About conference:

Conference Series invites all the participants from all over the world to attend "10th International Conference on Hypertension and Healthcare" during March 24-25, 2022 Paris, France. Which is mainly focuses on the “Awareness of High Blood Pressure”.This includes prompt keynote presentations, symposia, Poster presentations, speaker talks and Exhibition and workshops.

ME Conferences through its Open Access action is committed to build a real and reliable improvement to the scientific community. Conference Series Ltd organize 600+ Conferences once in a year across  Europe, USA & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 dominant personalities, reputed scientists as editorial board members.

Why to Attend?

Encounter the target market with members from across the world, committed to learn about hypertension treatment and health management. The meeting covers a large area of ability in the field not only of hypertension but also of other cardiovascular and metabolic disorders related to hypertension. Conduct presentations, distribute and update knowledge about the present situation of hypertension treatment and receive name appreciation at this 2 days event. World dominent speakers, latest treatment techniques, most recent researches and the advanced updates in Hypertension Management are the principal features of this conference.

Target Audience:

  • Doctors
  • Healthcare professionals
  • Vascular surgeons
  • Endocrinologists
  • Cardiologists
  • Laboratory members
  • Directors of Hypertension or related Programs or Associations
  • Writers
  • Scientists and Researchers organizers
  • Medical Colleges
  • Hospitals and Health Services
  • Heads, Deans and Professors of Hypertension or Cardiology departments
  • Founders and Employees of the related companies
  • Pharmaceutical companies
  • Clinical investigators
  • Training institution

 

Sessions/Tracks

Track 1: Hypertension

Hypertension, often known as high blood pressure, is a long-term medical disorder characterized by chronically excessive blood pressure in the arteries. The majority of the time, high blood pressure does not create any symptoms. High blood pressure for an extended period of time, on the other hand, is a substantial risk factor for stroke, coronary artery disease, heart failure, atrial fibrillation, peripheral arterial disease, vision loss, and chronic kidney disease.

  • Fitness & Exercise.
  • Heart Disease.
  • Metabolic Syndrome.                               

Track 2: Source of Hypertension 

A high-salt, high-fat, or potentially elevated cholesterol diet are for the most part normal reasons for hypertension. Kidney and chemical issues, diabetes, and inordinate cholesterol are altogether constant diseases. Hypertension runs in your family, particularly if your folks or other direct relations have it.

  • diet high in salt
  • fat
  • cholesterol.

Track 3: Pediatric Hypertension 

Elevated blood pressure is defined as blood pressure in the 90th percentile or higher for age, height, and sex in children younger than 13 years, while hypertension is defined as blood pressure in the 95th percentile or above.

Track 4: Hypertension, Stroke & Obesity 

Albeit both are associated with hypertension, focal fat circulation might be more firmly connected with stroke hazard than relative weight or weight record. A portion of this connection could be clarified by the way that focal stoutness addresses grown-up weight increment, which might be more applicable to stroke hazard than advanced age weight. Three attributes are connected to focal adiposity, hypertension, and stroke.

Track 5: Yoga and Naturopathic Treatments 

Physiotherapy is an allied health profession that treats impairments and enhances mobility and function by using mechanical force and movements (biomechanics or kinesiology), manual therapy, exercise therapy, and electrotherapy.

Track 6: Nursing Management of Hypertension 

Standard office-based approaches to manage hypertension show limited success. Such suboptimal hypertension manage reflects in part the absence of both an infrastructure for patient education and frequent, regular blood pressure  monitoring. We tested the efficacy of a physician-directed, nurse-managed, home-based system for hypertension management with standardized algorithms to modulate drug therapy, based on patients’ reports of home BP.

Track 7: Incidence and prognosis of refractory hypertension in patients with hypertension 

Among patients with hypertension who initiate treatment, 1 in 50 patients develops refractory hypertension. Patients with refractory hypertension are at increased risk of cardiovascular events, supporting the need for increased efforts to improve hypertension outcome in this population.

Track 8: Hypertension diagnosis 

When blood pressure is always measured at> 130 mmHg systolic blood pressure and> 80 mmHg diastolic blood pressure, it is diagnosed as hypertension. Blood pressure is measured with a blood pressure cuff, which is a non-invasive device that can detect the pressure in the arteries, using a blood pressure meter or electronic equipment to transmit the value. Your doctor may also use laboratory tests or imaging tests to diagnose certain causes or complications of high blood pressure.

Track 9: Hypertension and race/ethnicity 

Although there are still differences in the prevalence, control, and outcome of HTN compared to non-Hispanic whites, racial / ethnic minorities are underrepresented in genetic and clinical studies. Genomics has improved our understanding of HTN, but it does not have clinically useful applications. The role of social determinants of health in differences in hypertension is increasingly recognized. A team-based approach with targeted interventions at various levels can overcome barriers that have unique effects on minorities / minorities. Pulmonary hypertension in heart failure

Track 10: Treatment, and Control of Hypertension 

Diuretics are generally recommended as the first-line treatment for most hypertensive patients. However, if you have certain medical problems, your doctor may start using drugs other than diuretics as first-line treatment. For example, ACE inhibitors are often an option for diabetics.

  • water pills
  • Diuretics
  • ACE inhibitors

Track 11: Hypertension Control Among Patients Followed by Cardiologists

As many as one-third of the patients who are routinely followed up by cardiologists in the clinic have poor blood pressure control, and individual doctors' performance varies greatly.This variability, coupled with evidence that elevated blood pressure during visits is not usually taken for action, demonstrates a potential opportunity for quality improvement.

Track 12: Effect of Dietary Protein Supplementation on Blood Pressure

The results of this randomized controlled trial showed that in patients with prehypertension and stage 1 hypertension, the intake of soy and milk protein can reduce systolic blood pressure compared with refined high-glycemic carbohydrates. In addition, these findings indicate that substituting soy or milk protein for some carbohydrates may be an important part of nutritional intervention strategies for the prevention and treatment of hypertension.

  • dietary protein
  • carbohydrate
  • hypertension.

Track 13: Obesity and hypertension in the time of COVID-19 

Obesity, type 2 diabetes, chronic kidney disease or cardiovascular disease are known risk factors for severe COVID19 disease in people of any age. 10 Blacks, Hispanics/Latinos, American Indians/Alaska Natives, and Pacific Islanders have also increased their infection rates and disproportionately poor COVID19 results, including a higher risk of death than non-Hispanic whites.

  • syndrome coronavirus
  • coronavirus disease
  • respiratory syndrome coronavirus

Track14: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension is characterized by residual tissue clots that block the pulmonary vasculature 1, leading to increased pulmonary vascular resistance, progressive pulmonary hypertension, and right ventricular failure. Patients with chronic thromboembolic pulmonary hypertension have a poor prognosis unless they receive early treatment.

  • Pulmonary endarterectomy
  • chronic thromboembolic
  • pulmonary hypertension

Track 15: Advanced Treatments Approaches 

Lifestyle changes should be the initial method of hypertension management, including dietary intervention (salt reduction, potassium increase, alcohol avoidance and multifactorial diet control), weight loss, smoking cessation, physical exercise and stress management.

  • alcohol avoidance,
  • multifactorial diet control
  • weight reduction

 

 

To Collaborate Scientific Professionals around the World

Conference Date March 24-25, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by